If you can’t beat ‘em, regulate ‘em

We are fairly sure someone famous said that once. For those readers who haven’t been involved in pharma clinical development for the past 15 years, let us drop some knowledge on you. ‘Cause that’s what InsightCity does. 10 years ago, having clinical development operations in India was all the rage, companies were hiring in droves. Then came some quality issues and the wage gap closed and suddenly India was on the outs. In 2015, India revised some clinical trial guidelines. Apparently that was not enough, so last week the government made it mandatory for pharma to include Indian patients in global clinical trials if they want to market in India. One could argue this move helps ensure patient safety in India, but it will certainly help the local economy.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn